Article info
PDFTherapeutics
Randomised controlled trial
Sofosbuvir with ribavirin is safe and effective in hepatitis C genotype 1 with unfavourable pretreatment characteristics
- Correspondence to : Dr McKenzie C Ferguson, Department of Pharmacy Practice, Southern Illinois University, 220 University Park Drive, Box 2000, Edwardsville, IL 62026, USA; mcfergu{at}siue.edu
Citation
Sofosbuvir with ribavirin is safe and effective in hepatitis C genotype 1 with unfavourable pretreatment characteristics
Publication history
- First published December 12, 2013.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions